NCT05686096View on ClinicalTrials.gov

A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

April 8, 2023

Study Completion Date

April 8, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

MYK-224

Specified dose on specified days

Trial Locations (1)

53704-2526

Local Institution - 0001, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05686096 - A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435 | Biotech Hunter | Biotech Hunter